MYLAN-RIVASTIGMINE PATCH 10
MYLAN-RIVASTIGMINE PATCH 10
Approved
DIN Number
02423421
Drug Class
Human
Market Date
Dec 5, 2016
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02423421
AIG Number0140521008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06DA03 RIVASTIGMINE
Product Specifications
Dosage FormPatch
Route of AdministrationTransdermal
AHFS Classification12:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RIVASTIGMINEActive
Strength: 9.5 MG / 24 HOUR
Monograph: RIVASTIGMINE